Loading company details...
Latest Form 4 (Nov 20, 2025): Michael W. Dunne (Director): Purchase of 6,000 shares, $2.2K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 20, 2025 | Michael W. Dunne | Purchase | 6,000 | $2.2K |
| Aug 12, 2025 | Michael W. Dunne | Purchase | 15,000 | $10.9K |
| Jul 3, 2025 | Christine Coyne, Chief Commercial Officer | Grant/Award | 200,000 | n/a |
| Aug 12, 2024 | Michael W. Dunne | Exercise/Conversion | 106,247 | n/a |
| Aug 12, 2024 | Corey N. Fishman, Chief Executive Officer | Exercise/Conversion | 82,613 | n/a |
| Aug 12, 2024 | Ronald Hunt | Exercise/Conversion | 182,453 | n/a |
| Dec 27, 2023 | Michael W. Dunne | Purchase | 25,000 | $35.0K |
| Dec 19, 2023 | Michael W. Dunne | Purchase | 10,000 | $18.4K |
| Dec 4, 2023 | Sailaja Puttagunta, Chief Medical Officer | Grant/Award | 8,333 | n/a |
| Nov 27, 2023 | Michael W. Dunne | Purchase | 20,000 | $40.7K |